Aon/Sidley Webinar: Life Sciences Securities Class Action Update

Description

Life Sciences Securities Class Action Update: Legal and Risk Best Practices for Life Sciences Companies

In this webinar, Aon/Sidley will discuss:

• Overview and analysis of trends in decisions involving live sciences companies with products at two distinct stages of development – pre- and post-FDA approval and takeaways that can help guide disclosure approaches
• Recent cases and what those reveal about the events that can draw a lawsuit
• Insight into the D&O insurance underwriters’ reaction to the volatile life science shareholder litigation landscape